LAKE FOREST, Ill.--(BUSINESS WIRE)--Oct. 17, 2016-- IDEX Corporation (NYSE: IEX) today announced its financial results for the three month period ended September 30, 2016.

Third Quarter 2016 Highlights

• Orders were up 9 percent overall and up 2 percent organically
• Sales were up 5 percent overall and down 2 percent organically
• Reported EPS was 91 cents and adjusted EPS was 92 cents, up 3 percent
• Cash from operations of $125 million drove free cash flow of $114 million
• Acquired AWG Fittings and SFC Koenig for $288 million
• Divested two non-strategic product lines in the third quarter and one in early October

Third Quarter 2016

Orders of $530 million were up 9 percent (+2 percent organic, +8 percent acquisitions/divestitures and -1 percent foreign currency translation) compared with the prior year period.

Sales of $530 million were up 5 percent (-2 percent organic, +8 percent acquisitions/divestitures and -1 percent foreign currency translation) compared with the prior year period.

Gross margin of 43.5 percent was down 80 basis points from the prior year period, primarily due to $4.6 million of pre-tax fair value inventory step-up charges related to the AWG and SFC acquisitions.

Operating income of $109 million resulted in an operating margin of 20.5 percent. Adjusted for a $2.1 million pre-tax net loss on divestitures, adjusted operating income was $111 million with an adjusted operating margin of 20.9 percent, down 60 basis points from the prior year adjusted operating margin primarily due to the fair value inventory step-up charges. Operating income drove EBITDA of $133 million which was 25 percent of sales and covered interest expense by more than 11 times.

Net income was $70 million which drove EPS of 91 cents. Adjusted for the net loss on divestitures, adjusted EPS of 92 cents increased 3 cents, or 3 percent, from prior year adjusted EPS.

During the third quarter, we utilized $125 million of our global cash balances to partially fund the recent acquisitions. The usage of this cash resulted in a $5.2 million foreign withholding tax charge. Partially offsetting this incremental income tax expense was a favorable return-to-provision adjustment and other tax benefits, resulting in an effective tax rate of 29.6 percent compared to our prior tax rate guidance of 27.0 percent for the third quarter.

Cash from operations of $125 million was up 11 percent and drove free cash flow of $114 million which was 163 percent of net income.

“Orders grew 2 percent organically from strength in scientific and commercial markets, while industrial markets continued to face headwinds. Our team continued to execute extremely well in a challenging macro environment and our businesses are positioned to continue to perform. This performance is reflected in our strong third quarter cash conversion of 163 percent of net income and adjusted EPS of 92 cents, which includes 4 cents of fair value inventory step-up charges and a higher than expected effective tax rate, partially offset by favorable foreign exchange.

During the quarter, we deployed significant capital and resources to expand and optimize our portfolio. We completed the acquisitions of AWG and SFC, perfect complements to our Fire & Rescue and Sealing platforms. Year-to-date, we have deployed over $500 million on three strategic acquisitions and more recently, we have divested three non-strategic product lines. We will continue to use our healthy balance sheet and cash flow to invest aggressively in organic growth, fund disciplined M&A, pay consistent shareholder dividends and opportunistically repurchase stock.

In the face of continued market softness we expect to close out 2016 with solid execution and anticipate fourth quarter EPS of 92 to 94 cents. For the full year, we project total sales to be up 5 percent with organic revenue down 1 percent. Despite fourth quarter pressure from our recent product line divestitures and the SFC acquisition, including a 5 cent impact from the remaining fair value inventory step-up charge, we are maintaining the midpoint of our adjusted full year EPS guidance of $3.72 to $3.74, up 5 percent from the prior year.”

Andrew K. Silvernail

Chairman and Chief Executive Officer

Third Quarter 2016 Segment Highlights

Fluid & Metering Technologies

• Sales of $208 million reflected a 2 percent decrease compared to the third quarter of 2015 (flat organic, -1 percent divestitures and -1 percent foreign currency translation).
• Operating income of $56 million was $6 million higher than the prior year adjusted operating income. Operating margin of 26.7 percent represented a 340 basis point increase compared with the prior year adjusted operating margin primarily due to a $2.5 million pre-tax fair value inventory step-up charge included in the prior year.
• EBITDA of $63 million resulted in an EBITDA margin of 30.2 percent, a 340 basis point increase compared with prior year adjusted EBITDA.

Health & Science Technologies

• Sales of $184 million reflected a 1 percent decrease compared to the third quarter of 2015 (-1 percent organic, +2 percent acquisitions and -2 percent foreign currency translation).
• Operating income of $37 million was $3 million lower than the prior year adjusted operating income. Operating margin of 20.3 percent represented a 140 basis point decrease compared with the prior year adjusted operating margin primarily due to the $2.9 million pre-tax fair value inventory step-up charge related to the SFC acquisition.
• EBITDA of $49 million resulted in an EBITDA margin of 26.6 percent, a 160 basis point decrease compared with prior year adjusted EBITDA.

Fire & Safety/Diversified Products

• Sales of $139 million reflected a 30 percent increase compared to the third quarter of 2015 (-6 percent organic, +38 percent acquisition and -2 percent foreign currency translation).
• Operating income of $32 million was $1 million lower than the prior year adjusted operating income. Operating margin of 23.2 percent represented a 750 basis point decrease compared with the prior year adjusted operating margin primarily due to the dilutive impact of the 2016 acquisitions and the $1.7 million pre-tax fair value inventory step-up charge related to the AWG acquisition.
• EBITDA of $36 million resulted in an EBITDA margin of 26.1 percent, a 620 basis point decrease compared with prior year adjusted EBITDA.

For the third quarter of 2016, Fluid & Metering Technologies contributed 39 percent of sales, 44 percent of operating income and 43 percent of EBITDA; Health & Science Technologies accounted for 35 percent of sales, 30 percent of operating income and 33 percent of EBITDA; and Fire & Safety/Diversified Products represented 26 percent of sales, 26 percent of operating income and 24 percent of EBITDA.

Fourth Quarter Pension Settlement

IDEX has implemented a program offering certain former U.S. employees with a vested pension benefit an option to take a one-time lump sum distribution rather than future monthly pension payments. Payments will be made from the retirement plans during the fourth quarter of 2016. This action is expected to reduce IDEX’s pension benefit obligations by approximately $8 million by December 31, 2016.

This is part of IDEX’s overall plan to de-risk its pension plans and will not materially impact the plans’ funded status, materially impact future pension expense, or require additional contributions to the plans. Based on the estimated number of participants, IDEX expects to recognize a pretax pension settlement charge in the range of $3 million to $6 million in the fourth quarter of 2016. This settlement charge is excluded from our fourth quarter and full year guidance.

Non-U.S. GAAP Measures of Financial Performance

The Company supplements certain U.S. GAAP financial performance metrics with non-U.S. GAAP financial performance metrics in order to provide investors with better insight and increased transparency while also allowing for a more comprehensive understanding of the financial information used by management in its decision making. Reconciliations of non-U.S. GAAP financial performance metrics to their most comparable U.S. GAAP financial performance metrics are defined and presented below and should not be considered a substitute for, nor superior to, the financial data prepared in accordance with U.S. GAAP. There were no adjustments to U.S. GAAP financial performance metrics other than the items noted below.

• Organic orders and sales are calculated according to U.S. GAAP excluding amounts from acquired or divested businesses during the first twelve months of ownership or divestiture and the impact of foreign currency translation.
• Adjusted operating income is calculated as operating income plus restructuring expenses plus or minus the net loss or gain on sale of businesses.
• Adjusted operating margin is calculated as adjusted operating income divided by net sales.
• Adjusted net income is calculated as net income plus restructuring expenses plus or minus the loss or gain on sale of businesses, net of the statutory tax expense or benefit.
• EBITDA is calculated as net income plus interest expense plus provision for income taxes plus depreciation and amortization. We reconciled EBITDA to net income on a consolidated basis as we do not allocate consolidated interest expense or consolidated provision for income taxes to our segments.
• Adjusted EBITDA is calculated as EBITDA plus restructuring expenses plus or minus the loss or gain on sale of businesses.
• Free cash flow is calculated as cash flow from operating activities less capital expenditures.

Table 1: Reconciliations of Net Sales to Net Organic Sales
		For the Three Months Ended								For the Nine Months Ended
		September 30, 2016								September 30, 2016
		FMT		HST		FSDP		IDEX		FMT		HST		FSDP		IDEX
Change in net sales		(2%)		(1%)		30%		5%		(1%)		1%		18%		4%
- Net impact from acquisitions/divestitures		(1%)		2%		38%		8%		1%		2%		24%		7%
- Impact from FX		(1%)		(2%)		(2%)		(1%)		(1%)		(1%)		(1%)		(1%)
Organic net sales		0%		(1%)		(6%)		(2%)		(1%)		0%		(5%)		(2%)

Table 2: Reconciliations of Reported-to-Adjusted Operating Income and Margin (dollars in thousands)
			For the Three Months Ended September 30,
			2016																					2015
			FMT				HST				FSDP				Corporate				IDEX					FMT				HST				FSDP				Corporate				IDEX
Reported operating income (loss)			$	55,600			$	37,204			$	32,189			$	(16,136	)		$	108,857				$	46,910			$	38,371			$	32,536			$	3,996			$	121,813
+Restructuring expenses				-				-				-				-				-					2,505				1,774				279				165				4,723
+Net loss (gain) on sale of businesses				-				-				-				2,067				2,067					-				-				-				(18,070	)			(18,070	)
Adjusted operating income (loss)			$	55,600			$	37,204			$	32,189			$	(14,069	)		$	110,924				$	49,415			$	40,145			$	32,815			$	(13,909	)		$	108,466
Net sales (eliminations)			$	208,335			$	183,564			$	138,767			$	(310	)		$	530,356				$	212,101			$	184,893			$	107,009			$	(212	)		$	503,791
Operating margin				26.7	%			20.3	%			23.2	%			n/m				20.5	%				22.1	%			20.8	%			30.4	%			n/m				24.2	%
Adjusted operating margin				26.7	%			20.3	%			23.2	%			n/m				20.9	%				23.3	%			21.7	%			30.7	%			n/m				21.5	%
			For the Nine Months Ended September 30,
			2016																					2015
			FMT				HST				FSDP				Corporate				IDEX					FMT				HST				FSDP				Corporate				IDEX
Reported operating income (loss)			$	160,866			$	119,028			$	91,709			$	(47,213	)		$	324,390				$	154,665			$	117,888			$	91,180			$	(30,254	)		$	333,479
+Restructuring expenses				-				-				-				-				-					2,505				1,774				279				165				4,723
+Net loss (gain) on sale of businesses				-				-				-				2,067				2,067					-				-				-				(18,070	)			(18,070	)
Adjusted operating income (loss)			$	160,866			$	119,028			$	91,709			$	(45,146	)		$	326,457				$	157,170			$	119,662			$	91,459			$	(48,159	)		$	320,132
Net sales (eliminations)			$	641,988			$	556,475			$	384,996			$	(835	)		$	1,582,624				$	645,642			$	552,418			$	325,572			$	(2,762	)		$	1,520,870
Operating margin				25.1	%			21.4	%			23.8	%			n/m				20.5	%				24.0	%			21.3	%			28.0	%			n/m				21.9	%
Adjusted operating margin				25.1	%			21.4	%			23.8	%			n/m				20.6	%				24.3	%			21.7	%			28.1	%			n/m				21.0	%

Table 3: Reconciliations of Reported-to-Adjusted Net Income and EPS (in thousands, except EPS)
			For the Three Months									For the Nine Months
			Ended September 30,									Ended September 30,
			2016				2015					2016				2015
Reported net income			$	69,873			$	79,505				$	213,762			$	215,044
+Restructuring expenses				-				4,723					-				4,723
+Tax impact on restructuring expenses				-				(1,638	)				-				(1,638	)
+Net loss (gain) on sale of businesses				2,067				(18,070	)				2,067				(18,070	)
+Tax impact on net loss (gain) on sale of businesses				(1,467	)			4,839					(1,467	)			4,839
Adjusted net income			$	70,473			$	69,359				$	214,362			$	204,898
Reported EPS			$	0.91			$	1.02				$	2.78			$	2.75
+Restructuring expenses				-				0.06					-				0.06
+Tax impact on restructuring expenses				-				(0.02	)				-				(0.02	)
+Net loss (gain) on sale of businesses				0.03				(0.23	)				0.03				(0.23	)
+Tax impact on net loss (gain) on sale of businesses				(0.02	)			0.06					(0.02	)			0.06
Adjusted EPS			$	0.92			$	0.89				$	2.79			$	2.62
Diluted weighted average shares				76,880				77,646					76,742				78,266

Table 4: Reconciliations of EBITDA to Net Income (in thousands)
			For the Three Months Ended September 30,
			2016																					2015
			FMT				HST				FSDP				Corporate				IDEX					FMT				HST				FSDP				Corporate				IDEX
Operating income (loss)			$	55,600			$	37,204			$	32,189			$	(16,136	)		$	108,857				$	46,910			$	38,371			$	32,536			$	3,996			$	121,813
- Other (income) expense - net				(136	)			(375	)			(498	)			(1,355	)			(2,364	)				(82	)			(877	)			(247	)			513				(693	)
+ Depreciation and amortization				7,168				11,163				3,584				277				22,192					7,311				11,179				1,513				374				20,377
EBITDA				62,904				48,742				36,271				(14,504	)			133,413					54,303				50,427				34,296				3,857				142,883
- Interest expense																				11,913																					10,229
- Provision for income taxes																				29,435																					32,772
- Depreciation and amortization																				22,192																					20,377
Net income																			$	69,873																				$	79,505
Net sales (eliminations)			$	208,335			$	183,564			$	138,767			$	(310	)		$	530,356				$	212,101			$	184,893			$	107,009			$	(212	)		$	503,791
Operating margin				26.7	%			20.3	%			23.2	%			n/m				20.5	%				22.1	%			20.8	%			30.4	%			n/m				24.2	%
EBITDA margin				30.2	%			26.6	%			26.1	%			n/m				25.2	%				25.6	%			27.3	%			32.0	%			n/m				28.4	%
			For the Nine Months Ended September 30,
			2016																					2015
			FMT				HST				FSDP				Corporate				IDEX					FMT				HST				FSDP				Corporate				IDEX
Operating income (loss)			$	160,866			$	119,028			$	91,709			$	(47,213	)		$	324,390				$	154,665			$	117,888			$	91,180			$	(30,254	)		$	333,479
- Other (income) expense - net				(350	)			(1,505	)			(1,342	)			(1,785	)			(4,982	)				(894	)			(347	)			(1,091	)			743				(1,589	)
+ Depreciation and amortization				22,011				33,044				8,316				953				64,324					20,321				31,874				4,574				1,205				57,974
EBITDA				183,227				153,577				101,367				(44,475	)			393,696					175,880				150,109				96,845				(29,792	)			393,042
- Interest expense																				33,607																					31,410
- Provision for income taxes																				82,003																					88,614
- Depreciation and amortization																				64,324																					57,974
Net income																			$	213,762																				$	215,044
Net sales (eliminations)			$	641,988			$	556,475			$	384,996			$	(835	)		$	1,582,624				$	645,642			$	552,418			$	325,572			$	(2,762	)		$	1,520,870
Operating margin				25.1	%			21.4	%			23.8	%			n/m				20.5	%				24.0	%			21.3	%			28.0	%			n/m				21.9	%
EBITDA margin				28.5	%			27.6	%			26.3	%			n/m				24.9	%				27.2	%			27.2	%			29.7	%			n/m				25.8	%

Table 5: Reconciliations of EBITDA to Adjusted EBITDA (in thousands)
			For the Three Months Ended September 30,
			2016																					2015
			FMT				HST				FSDP				Corporate				IDEX					FMT				HST				FSDP				Corporate				IDEX
EBITDA			$	62,904			$	48,742			$	36,271			$	(14,504	)		$	133,413				$	54,303			$	50,427			$	34,296			$	3,857			$	142,883
+Restructuring expenses				-				-				-				-				-					2,505				1,774				279				165				4,723
+Net loss (gain) on sale of businesses				-				-				-				2,067				2,067					-				-				-				(18,070	)			(18,070	)
Adjusted EBITDA			$	62,904			$	48,742			$	36,271			$	(12,437	)		$	135,480				$	56,808			$	52,201			$	34,575			$	(14,048	)		$	129,536
Adjusted EBITDA margin				30.2	%			26.6	%			26.1	%			n/m				25.5	%				26.8	%			28.2	%			32.3	%			n/m				25.7	%
			For the Nine Months Ended September 30,
			2016																					2015
			FMT				HST				FSDP				Corporate				IDEX					FMT				HST				FSDP				Corporate				IDEX
EBITDA			$	183,227			$	153,577			$	101,367			$	(44,475	)		$	393,696				$	175,880			$	150,109			$	96,845			$	(29,792	)		$	393,042
+Restructuring expenses				-				-				-				-				-					2,505				1,774				279				165				4,723
+Net loss (gain) on sale of businesses				-				-				-				2,067				2,067					-				-				-				(18,070	)			(18,070	)
Adjusted EBITDA			$	183,227			$	153,577			$	101,367			$	(42,408	)		$	395,763				$	178,385			$	151,883			$	97,124			$	(47,697	)		$	379,695
Adjusted EBITDA margin				28.5	%			27.6	%			26.3	%			n/m				25.0	%				27.6	%			27.5	%			29.8	%			n/m				25.0	%

Table 6: Reconciliations of Free Cash Flow (in thousands)
		For the Three Months Ended
		September 30,							June 30,
		2016			2015				2016
Cash flow from operating activities		$	125,480		$	113,353			$	88,478
- Capital expenditures			11,590			8,785				8,402
+ Excess tax benefit from share-based compensation *			-			267				-
Free cash flow		$	113,890		$	104,835			$	80,076
* The Company early adopted ASU 2016-09 effective in the first quarter of 2016. This ASU issued in March of 2016 simplifies the accounting for share-based payments, including the presentation of the excess tax benefit on the statement of cash flows.

Conference Call to be Broadcast over the Internet

IDEX will broadcast its third quarter earnings conference call over the Internet on Tuesday, October 18, 2016 at 9:30 a.m. CT. Chairman and Chief Executive Officer Andy Silvernail and Vice President, Chief Financial Officer and Chief Accounting Officer Mike Yates will discuss the Company’s recent financial performance and respond to questions from the financial analyst community. IDEX invites interested investors to listen to the call and view the accompanying slide presentation, which will be carried live on its website at www.idexcorp.com. Those who wish to participate should log on several minutes before the discussion begins. After clicking on the presentation icon, investors should follow the instructions to ensure their systems are set up to hear the event and view the presentation slides, or download the correct applications at no charge. Investors will also be able to hear a replay of the call by dialing 877.660.6853 (or 201.612.7415 for international participants) using the ID #13620008.

Forward-Looking Statements

This news release contains “forward-looking” statements within the meaning of the Private Securities Litigation Reform Act of 1995, as amended. These statements may relate to, among other things, capital expenditures, acquisitions, cost reductions, cash flow, revenues, earnings, market conditions, global economies and operating improvements, and are indicated by words or phrases such as “anticipate,” “estimate,” “plans,” “expects,” “projects,” “forecasts,” “should,” “could,” “will,” “management believes,” “the Company believes,” “the Company intends,” and similar words or phrases. These statements are subject to inherent uncertainties and risks that could cause actual results to differ materially from those anticipated at the date of this news release. The risks and uncertainties include, but are not limited to, the following: economic and political consequences resulting from terrorist attacks and wars; levels of industrial activity and economic conditions in the U.S. and other countries around the world; pricing pressures and other competitive factors, and levels of capital spending in certain industries – all of which could have a material impact on order rates and IDEX’s results, particularly in light of the low levels of order backlogs it typically maintains; its ability to make acquisitions and to integrate and operate acquired businesses on a profitable basis; the relationship of the U.S. dollar to other currencies and its impact on pricing and cost competitiveness; political and economic conditions in foreign countries in which the company operates; interest rates; capacity utilization and the effect this has on costs; labor markets; market conditions and material costs; and developments with respect to contingencies, such as litigation and environmental matters. Additional factors that could cause actual results to differ materially from those reflected in the forward-looking statements include, but are not limited to, the risks discussed in the “Risk Factors” section included in the Company’s most recent annual report on Form 10-K filed with the SEC and the other risks discussed in the Company’s filings with the SEC. The forward-looking statements included here are only made as of the date of this news release, and management undertakes no obligation to publicly update them to reflect subsequent events or circumstances, except as may be required by law. Investors are cautioned not to rely unduly on forward-looking statements when evaluating the information presented here.

About IDEX

IDEX Corporation is an applied solutions company specializing in fluid and metering technologies, health and science technologies, and fire, safety and other diversified products built to its customers’ exacting specifications. Its products are sold in niche markets to a wide range of industries throughout the world. IDEX shares are traded on the New York Stock Exchange and Chicago Stock Exchange under the symbol “IEX”.

For further information on IDEX Corporation and its business units, visit the company’s website at www.idexcorp.com.

(Financial reports follow)

IDEX CORPORATION
Condensed Consolidated Statements of Operations
(in thousands except per share amounts)
(unaudited)
			Three Months Ended								Nine Months Ended
			September 30,								September 30,
			2016				2015				2016				2015
Net sales			$	530,356			$	503,791			$	1,582,624			$	1,520,870
Cost of sales				299,467				280,531				884,342				839,954
Gross profit				230,889				223,260				698,282				680,916
Selling, general and administrative expenses				119,965				114,794				371,825				360,784
Restructuring expenses				-				4,723				-				4,723
Net loss (gain) on sale of businesses				2,067				(18,070	)			2,067				(18,070	)
Operating income				108,857				121,813				324,390				333,479
Other (income) expense - net				(2,364	)			(693	)			(4,982	)			(1,589	)
Interest expense				11,913				10,229				33,607				31,410
Income before income taxes				99,308				112,277				295,765				303,658
Provision for income taxes				29,435				32,772				82,003				88,614
Net income			$	69,873			$	79,505			$	213,762			$	215,044
Earnings per Common Share (a):
Basic earnings per common share			$	0.92			$	1.03			$	2.81			$	2.77
Diluted earnings per common share			$	0.91			$	1.02			$	2.78			$	2.75
Share Data:
Basic weighted average common shares outstanding				75,819				76,831				75,753				77,431
Diluted weighted average common shares outstanding				76,880				77,646				76,742				78,266

Condensed Consolidated Balance Sheets
(in thousands)
(unaudited)
							September 30,				December 31,
							2016				2015
Assets
Current assets
Cash and cash equivalents							$	239,397			$	328,018
Receivables - net								287,329				260,000
Inventories								276,013				239,124
Other current assets								54,614				35,542
Total current assets								857,353				862,684
Property, plant and equipment - net								261,092				240,945
Goodwill and intangible assets								2,125,322				1,684,366
Other noncurrent assets								18,697				17,448
Total assets							$	3,262,464			$	2,805,443
Liabilities and shareholders' equity
Current liabilities
Trade accounts payable							$	117,430			$	128,911
Accrued expenses								160,816				153,672
Short-term borrowings								1,171				1,087
Dividends payable								25,940				25,927
Total current liabilities								305,357				309,597
Long-term borrowings								1,099,601				839,707
Other noncurrent liabilities								302,763				212,848
Total liabilities								1,707,721				1,362,152
Shareholders' equity								1,554,743				1,443,291
Total liabilities and shareholders' equity							$	3,262,464			$	2,805,443

IDEX CORPORATION
Condensed Consolidated Statements of Cash Flow
(in thousands)
(unaudited)
			Nine Months Ended September 30,
			2016						2015
Cash flows from operating activities
Net income			$	213,762					$	215,044
Adjustments to reconcile net income to net cash provided by operating activities:
Net loss (gain) on sale of businesses				2,067						(18,070	)
Depreciation and amortization				28,360						26,634
Amortization of intangible assets				35,964						31,340
Amortization of debt issuance costs				1,150						1,233
Share-based compensation expense				15,325						14,735
Deferred income taxes				4,880						1,473
Excess tax benefit from share-based compensation				-						(4,350	)
Non-cash interest expense associated with forward starting swaps				5,144						5,287
Changes in (net of the effect from acquisitions and divestitures):
Receivables				(2,178	)					(1,417	)
Inventories				22,250						(6,474	)
Other current assets				(18,276	)					(2,742	)
Trade accounts payable				(16,696	)					(4,002	)
Accrued expenses				(2,982	)					2,067
Other — net				(4,446	)					1,023
Net cash flows provided by operating activities				284,324						261,781
Cash flows from investing activities
Additions of property, plant and equipment				(28,642	)					(32,611	)
Acquisition of businesses, net of cash acquired				(510,001	)					(193,163	)
Proceeds from sale of businesses, net of cash sold				32,529						27,677
Other — net				(73	)					647
Net cash flows used in investing activities				(506,187	)					(197,450	)
Cash flows from financing activities
Borrowings under revolving facilities				460,524						383,621
Proceeds from 3.20% Senior Notes				100,000						-
Proceeds from 3.37% Senior Notes				100,000						-
Payments under revolving facilities				(402,172	)					(295,934	)
Payment of 2.58% Senior Euro Notes				-						(88,420	)
Debt issuance costs				(246	)					(1,698	)
Dividends paid				(77,367	)					(71,673	)
Proceeds from stock option exercises				23,154						15,167
Excess tax benefit from share-based compensation				-						4,350
Purchase of common stock				(57,272	)					(177,772	)
Unvested shares surrendered for tax withholding				(4,899	)					(3,217	)
Net cash flows provided by (used in) financing activities				141,722						(235,576	)
Effect of exchange rate changes on cash and cash equivalents				(8,480	)					(31,410	)
Net decrease in cash				(88,621	)					(202,655	)
Cash and cash equivalents at beginning of year				328,018						509,137
Cash and cash equivalents at end of period			$	239,397					$	306,482

IDEX CORPORATION
Company and Segment Financial Information - Reported
(dollars in thousands)
(unaudited)
					Three Months Ended										Nine months Ended
					September 30, (b)										September 30, (b)
					2016					2015					2016					2015
		Fluid & Metering Technologies
		Net sales			$	208,335				$	212,101				$	641,988				$	645,642
		Operating income (c)				55,600					46,910					160,866					154,665
		Operating margin				26.7		%			22.1		%			25.1		%			24.0		%
		EBITDA			$	62,904				$	54,303				$	183,227				$	175,880
		EBITDA margin				30.2		%			25.6		%			28.5		%			27.2		%
		Depreciation and amortization			$	7,168				$	7,311				$	22,011				$	20,321
		Capital expenditures				5,091					4,325					12,704					17,849
		Health & Science Technologies
		Net sales			$	183,564				$	184,893				$	556,475				$	552,418
		Operating income (c)				37,204					38,371					119,028					117,888
		Operating margin				20.3		%			20.8		%			21.4		%			21.3		%
		EBITDA			$	48,742				$	50,427				$	153,577				$	150,109
		EBITDA margin				26.6		%			27.3		%			27.6		%			27.2		%
		Depreciation and amortization			$	11,163				$	11,179				$	33,044				$	31,874
		Capital expenditures				4,450					3,193					11,455					8,755
		Fire & Safety/Diversified Products
		Net sales			$	138,767				$	107,009				$	384,996				$	325,572
		Operating income (c)				32,189					32,536					91,709					91,180
		Operating margin				23.2		%			30.4		%			23.8		%			28.0		%
		EBITDA			$	36,271				$	34,296				$	101,367				$	96,845
		EBITDA margin				26.1		%			32.0		%			26.3		%			29.7		%
		Depreciation and amortization			$	3,584				$	1,513				$	8,316				$	4,574
		Capital expenditures				2,034					1,016					4,305					4,128
		Corporate Office and Eliminations
		Intersegment sales eliminations			$	(310	)			$	(212	)			$	(835	)			$	(2,762	)
		Operating income (loss) (c)				(16,136	)				3,996					(47,213	)				(30,254	)
		EBITDA				(14,504	)				3,857					(44,475	)				(29,792	)
		Depreciation and amortization				277					374					953					1,205
		Capital expenditures				15					251					178					1,879
		Company
		Net sales			$	530,356				$	503,791				$	1,582,624				$	1,520,870
		Operating income				108,857					121,813					324,390					333,479
		Operating margin				20.5		%			24.2		%			20.5		%			21.9		%
		EBITDA			$	133,413				$	142,883				$	393,696				$	393,042
		EBITDA margin				25.2		%			28.4		%			24.9		%			25.8		%
		Depreciation and amortization (d)			$	22,192				$	20,377				$	64,324				$	57,974
		Capital expenditures				11,590					8,785					28,642					32,611
(a)		Calculated by applying the two-class method of allocating earnings to common stock and participating securities as required by ASC 260, Earnings Per Share.
(b)		Three and nine month data includes acquisition of Alfa Valvole (June 2015) in the Fluid & Metering Technologies segment, Novotema (June 2015), CiDRA Precision Services (July 2015) and SFC Koenig (September 2016) in the Health & Science Technologies segment and Akron Brass (March 2016) and AWG Fittings (July 2016) in the Fire & Safety/Diversified segment from the date of acquisition. Three and nine month data also includes the results of Hydra-Stop (July 2016) in the Fluid & Metering Technologies segment and Melles Griot KK (September 2016) and Ismatec (July 2015) in the Health & Science Technologies segment through the date of disposition.
(c)		Segment operating income excludes unallocated corporate operating expenses which are included in Corporate Office and Eliminations.
(d)		Depreciation and amortization excludes amortization of debt issuance costs.

View source version on businesswire.com: http://www.businesswire.com/news/home/20161017006522/en/

Source: IDEX Corporation

IDEX Corporation
Investor Contact:
Mike Yates
Vice President, Chief Financial Officer & Chief Accounting Officer
(847) 498-7070